The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Inittowinit sounds a bit b...hurt that he didn't sell when Trevor did. He didn't sell out overnight. He was selling for months. You could've looked and done the same and made money like Trevor. Now he's buying BRH again. He's everything you're not. He knows when to buy and when to sell his holdings. And he doesn't go around whining online.
Daily volume of £10k... who cares where it goes on a volume like this. This is a startup share. It moves on the news and goes down on lack of it. The current global markets situation just exacerbates it. If you want a daily winner out of this share you're doing it wrong.
It has been, and continues to be, a long term bet. They've doubled sales last year and they've got a lot of stuff in the pipeline still. Don't see what are you basing your negativity on.
There's just no enough news recently, it's been drifting down. But it's got a lot going for it this year. Further increases in ARR for existing software solutions, as they become the de facto standard for scan comparisons (they're spending a lot of time and energy building the brand awarness in the industry). Then there's the gad free imaging application that should be sorted by autumn, during a year where there are giant shortages of contrast agent as well as increasing awareness of its potential toxicity. And finally the canceer trial, tho this one is going to take longer, some information should start leaking through the quarterly reports.
This 'little' company has a massive potential.
Well if only you listened to the troll when the share was at 16p... all that money you could have made...
But keep telling yourself I'm a troll as this share returns to its natural habitat around 3-5p
I'm not frustrated at all, I've been here a long time with an average just a little north o 3p, sold it all at 17ish. Could've done a little better, but still very happy.
Still on this board because
a) I hate the ramping that is being done the exact same way that was done after Stonechecker... and that ended up going all the way back to 3p after a high of 16p.
b) I might buy back into this if it falls down to < 5p, which I expect it will this year. Exactly like it did after Stonechecker.
Ultimately this comapny has delivered absolutely no return on investment. They got some stuff approved, it might sell in the future... or it might not. Valuing that at 20mil is absolute insanity. There's people on here claiming Stonechecker alone will be 100s of millions... yeah... right. I've got a bridge to sell you if you believe that.
@Kiwi_ you mean when everyone sells? CE is already priced in and people like you waiting for it hoping for a miracle is the only reason this stock isn't back to single digits yet. And it will be the moment that kicks in. Might be a short ramp... maybe. Or just a massive sell off from all the rampers similar to yourself the moment the news kicks in. As pretty much everyone expects it to follow through given FDA approval. And it so far still leads to no income at all for the foreseeable future.